China Unveils Major Highlights In 12th Five-Year Biopharma Plans
This article was originally published in PharmAsia News
Executive Summary
According to China’s National Development and Reform Commission, the country’s 12th Five-Year biopharma development plans will center on innovation, product quality, industry consolidation, environmental protection, and societal benefits.